1+ hour, 27+ min ago   (328+ words) By Mark B. Johnson, BS; Evan Hicks; and Sandra Marchese Johnson, MD, FAAD Men are increasingly investing in their haircare. Here, we review what men are searching for on Instagram via certain hashtags and compare it to medical literature to identify…...

6+ hour, 49+ min ago   (262+ words) The Dermatology Digest Americans Still Embrace Outdoor Tanning Despite Risks Despite a large body of research linking intentional outdoor tanning to skin cancer and premature aging, it is still commonplace in the US. This is the main takeaway from a…...

3+ day, 23+ hour ago   (82+ words) The Dermatology Digest From the Podium to Your Practice With Dr. Sandra Marchese Johnson Sandra Marchese Johnson, MD, FAAD, a Dermatologist in private practice in Fort Smith, AR, and a member of the American Academy of Dermatology’s Board of Directors,…...

5+ day, 6+ hour ago   (538+ words) The Dermatology Digest SKNV Secures Exclusive Commercialization Rights for Kefunova Cream SKNV now has exclusive commercialization rights to the patent portfolio owned by Washington University in St. Louis, covering the combination of Fluorouracil and Calcipotriene therapies, which is currently available…...

6+ day, 3+ hour ago   (374+ words) The Dermatology Digest With Direct Sales Force for Letybo and New K-TOX Campaign, Hugel Aesthetics Expands U.S. Presence Hugel Aesthetics is launching a dedicated direct sales and field-based medical affairs organization for letibotulinumtoxinA-wlbg (Letybo) and investing in a new consumer K-TOX…...

6+ day, 8+ hour ago   (338+ words) Merz Aesthetics is bringing back its Neocutis Journée Revitalizing Day Cream SPF 30. Journée returns to the Neocutis portfolio, following the discontinuation of the Journée Firm line, in response to consumer feedback and a renewed commitment to the…...

6+ day, 8+ hour ago   (194+ words) Survey-based research is a commonly used in dermatology to gauge patient satisfaction or identify gaps in education, diagnosis, and care. Despite this, survey responsiveness among physicians is notably low. Now, a new study suggests that early morning solicitation and financial…...

1+ week, 5+ day ago   (221+ words) New From L’Oréal Paris: Revitalift Melasyl Dark Spot Creamy-Serum The Dermatology Digest New From L’Oréal Paris: Revitalift Melasyl Dark Spot Creamy-Serum L’Oréal Paris is launching Revitalift Melasyl Dark Spot Creamy-Serum to correct dark spots, improve skin tone, and smooth wrinkles....

1+ week, 5+ day ago   (156+ words) Neutrogena ‘Breaks the Rules’ With Science for New Campaign The Dermatology Digest Neutrogena ‘Breaks the Rules’ With Science for New Campaign Neutrogena is rolling out Break the Rules, a new campaign designed to help consumers embrace science-backed solutions. “Patients now…...

1+ week, 6+ day ago   (112+ words) HBI-8000 in combination with nivolumab (Opdivo, BMS) met its primary endpoint in a Phase 3 trial of patients with advanced melanoma, according to topline results reported by HUYABIO International. Patients receiving HBI-8000 plus nivolumab achieved a median progression-free survival of 11.7 months,…...